Looking at the Big Picture for Johnson & Johnson (JNJ)

Johnson & Johnson (NYSE:JNJ) is an interesting stock at present. Now trading with a market value of 365.96B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Johnson & Johnson (NYSE:JNJ) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For JNJ, the company currently has 20.91 billion of cash on the books, which is offset by 5.36 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 144.92 billion in total assets, balanced by 74.58 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Johnson & Johnson (JNJ) saw 2.35 billion in free cash flow last quarter, representing a quarterly net change in cash of 1.94 billion. Perhaps most importantly where cash movements are concerned, the company saw about 2.91 billion in net operating cash flow.

Johnson & Johnson (NYSE:JNJ) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 17.8 billion in total revenues. That represents a quarterly year/year change in revenues of 0.02 in sequential terms, the JNJ saw sales decline by -0.02.

But what about the bottom line? After all, that’s what really matters in the end. Johnson & Johnson (JNJ) is intriguing when broken down to its core data. The cost of selling goods last quarter was 5.35 billion, yielding a gross basic income of 12.45 billion. For shareholders, given the total diluted outstanding shares of 2.75 billion, this means overall earnings per share of 1.61. Note, this compares with a consensus analyst forecast of 1.77 in earnings per share for its next fiscal quarterly report.

Is Johnson & Johnson (NYSE:JNJ) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 7.72 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 17.06. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Johnson & Johnson.

Previous ArticleNext Article

Related Post

Technical Indicators Turn Indifferent For Groupon,... Groupon, Inc. (NASDAQ:GRPN) fell by -0.22% in Monday’s trading session from $4.64 to $4.63. The price has fallen in 6 of the last 10 days and is down ...
Technical Indicators Turn Indifferent For Kinross ... Kinross Gold Corporation (NYSE:KGC) fell by -1.18% in Monday’s trading session from $4.24 to $4.19 and has now fallen 3 consecutive sessions. The pric...
General Motors Company (GM) is better stock pick t... The shares of General Motors Company have increased by more than 20.61% this year alone. The shares of Cleveland-Cliffs Inc. (NYSE:CLF), has slumped b...
How Does the Fundamental Picture Look for Amazon.c..., Inc. (NASDAQ:AMZN) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a market value...
Uncovering the next great stocks: Accelerate Diagn... The shares of Accelerate Diagnostics, Inc. shares recently went up by 6.68% or $1.3 and now trades at $20.75. The shares of Sorrento Tech, Inc. (NASDA...